relapsing polychondritis: Relapsing polychondritis (RP) is a rare, clinically heterogeneous, multisystemic inflammatory disease characterized by inflammation of the cartilage and proteoglycan rich structures leading to cartilage damage with joint, ocular and cardiovascular involvement.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
83 |
4. Check minimum number of eventsNone |
83 |
5. Include endpointsNone |
83 |
6. Filter based on genotype QC (FinnGen only) |
80 |
Control definitions (FinnGen only)
- Control exclude
- M13_OTHERBONE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M94
- Name in latin
- Polychondritis recidiva
Similar endpoints
↥List of similar endpoints to
Relapsing polychondritis
based on the number of shared cases.
Similar with more cases:
- Chondropathies
- Other disorders of bone
- Osteopathies and chondropathies
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 349 | 227 | 121 |
| Only index persons | 333 | 217 | 116 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 52.03 | 50.64 | 54.42 |
| Only index persons | 51.38 | 50.03 | 53.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 80 | 56 | 24 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 51.31 | 49.81 | 54.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 83
- Matched controls
- 830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M941, ,
ICD-10 Finland
Relapsing polychondritis
+∞
119.5
83
*
J01DB01, ,
ATC
cefalexin; oral
+∞
111.5
80
*
A98, ,
ICD-O-3
+∞
109.2
79
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
106.9
78
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
96.8
73
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
87.7
68
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
87.7
68
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
82.6
65
*
SAA01, ,
ICD-O-3
+∞
77.7
62
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
77.7
62
*
WX110, ,
ICD-O-3
+∞
68.5
56
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
65.5
54
*
J01DA01, ,
ATC
[U] cefalexin
+∞
65.5
54
*
SAA02, ,
ICD-O-3
+∞
64.1
53
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
64.1
53
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
62.6
52
*
GD1AA, ,
ICD-O-3
+∞
61.2
51
*
L04AX03, ,
ATC
methotrexate; systemic
+∞
61.2
51
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
58.4
49
*
M03BX02, ,
ATC
tizanidine; oral
+∞
58.4
49
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
58.4
49
*
K021, ,
ICD-O-3
+∞
58.4
49
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
58.4
49
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
57.0
48
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
57.0
48
*
SFA20, ,
ICD-O-3
+∞
55.6
47
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
55.6
47
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
52.9
45
*
SFA10, ,
ICD-O-3
+∞
52.9
45
*
R06AE07, ,
ATC
cetirizine; oral
+∞
52.9
45
*
EB1AA, ,
ICD-O-3
+∞
52.9
45
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
51.5
44
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
50.2
43
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
48.9
42
*
UJD10, ,
ICD-O-3
+∞
47.5
41
*
WYA05, ,
ICD-O-3
+∞
47.5
41
*
ZXE00, ,
ICD-O-3
+∞
47.5
41
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
47.5
41
*
M941, ,
ICD-O-3
+∞
44.9
39
*
E0000UV, ,
ATC
+∞
44.9
39
*
KMAK, ,
ICD-O-3
+∞
43.6
38
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
43.6
38
*
J069, ,
ICD-O-3
+∞
42.4
37
*
R01AD09, ,
ATC
mometasone; nasal
+∞
42.4
37
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
41.1
36
*
ZXD10, ,
ICD-O-3
+∞
41.1
36
*
WX290, ,
ICD-O-3
+∞
41.1
36
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
41.1
36
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
41.1
36
*
WZB00, ,
ICD-O-3
+∞
39.8
35
*
EB1SA, ,
ICD-O-3
+∞
39.8
35
*
-1, ,
ICD-O-3
+∞
39.8
35
*
Z871, ,
ICD-O-3
+∞
39.8
35
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
38.6
34
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
38.6
34
*
M796, ,
ICD-O-3
+∞
38.6
34
*
SFA30, ,
ICD-O-3
+∞
38.6
34
*
SDA03, ,
ICD-O-3
+∞
38.6
34
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
38.6
34
*
ZXE10, ,
ICD-O-3
+∞
37.3
33
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
37.3
33
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
37.3
33
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
37.3
33
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
37.3
33
*
EB1HA, ,
ICD-O-3
+∞
37.3
33
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
37.3
33
*
Z3231, ,
ICD-O-3
+∞
36.1
32
*
S18, ,
ICD-O-3
+∞
34.9
31
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
34.9
31
*
SPAT1256, ,
ICD-O-3
+∞
34.9
31
*
R74, ,
ICD-O-3
+∞
34.9
31
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
33.6
30
*
Z2221, ,
ICD-O-3
+∞
33.6
30
*
Z012, ,
ICD-O-3
+∞
32.4
29
*
SPAT1263, ,
ICD-O-3
+∞
32.4
29
*
ZXD05, ,
ICD-O-3
+∞
32.4
29
*
M02AA07, ,
ATC
piroxicam; topical
+∞
32.4
29
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
32.4
29
*
SPAT1249, ,
ICD-O-3
+∞
31.2
28
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
31.2
28
*
SAA03, ,
ICD-O-3
+∞
30.0
27
*
WZC00, ,
ICD-O-3
+∞
30.0
27
*
EBA00, ,
ICD-O-3
+∞
30.0
27
*
D07AC01, ,
ATC
betamethasone; topical
+∞
28.8
26
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
28.8
26
*
SCA01, ,
ICD-O-3
+∞
28.8
26
*
D82, ,
ICD-O-3
+∞
28.8
26
*
M255, ,
ICD-O-3
+∞
28.8
26
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
28.8
26
*
N05CF01, ,
ATC
zopiclone; oral
+∞
27.6
25
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
27.6
25
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
27.6
25
*
R06AX27, ,
ATC
desloratadine; oral
+∞
27.6
25
*
R4110, ,
ICD-O-3
+∞
27.6
25
*
SDA02, ,
ICD-O-3
+∞
26.5
24
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
26.5
24
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
26.5
24
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
26.5
24
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
26.5
24
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
26.5
24
*
SDA01, ,
ICD-O-3
+∞
25.3
23
*
UJF32, ,
ICD-O-3
+∞
25.3
23
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
25.3
23
*
M545, ,
ICD-O-3
+∞
25.3
23
*
H02AB07, ,
ATC
prednisone; oral
+∞
25.3
23
*
R05, ,
ICD-O-3
+∞
25.3
23
*
I10, ,
ICD-O-3
+∞
25.3
23
*
L17, ,
ICD-O-3
+∞
25.3
23
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
24.1
22
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
24.1
22
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
24.1
22
*
N03AX16, ,
ATC
[U] pregabalin
+∞
24.1
22
*
C10AA01, ,
ATC
simvastatin; oral
+∞
24.1
22
*
D19, ,
ICD-O-3
+∞
24.1
22
*
AA1AD, ,
ICD-O-3
+∞
24.1
22
*
R03DC03, ,
ATC
montelukast; oral
+∞
24.1
22
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
24.1
22
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
24.1
22
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
24.1
22
*
D07AC13, ,
ATC
mometasone; topical
+∞
24.1
22
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
23.0
21
*
N05BA04, ,
ATC
oxazepam; oral
+∞
23.0
21
*
L08, ,
ICD-O-3
+∞
23.0
21
*
ZXA00, ,
ICD-O-3
+∞
23.0
21
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
23.0
21
*
M01AX17, ,
ATC
nimesulide; oral
+∞
23.0
21
*
LC2BE, ,
ICD-O-3
+∞
23.0
21
*
OAB43, ,
ICD-O-3
+∞
23.0
21
*
P01BA02, ,
ATC
hydroxychloroquine; oral
+∞
23.0
21
*
SPAT1223, ,
ICD-O-3
+∞
23.0
21
*
ZXA05, ,
ICD-O-3
+∞
21.8
20
*
L15, ,
ICD-O-3
+∞
21.8
20
*
SFC01, ,
ICD-O-3
+∞
21.8
20
*
EBA05, ,
ICD-O-3
+∞
21.8
20
*
R83, ,
ICD-O-3
+∞
21.8
20
*
K0382, ,
ICD-O-3
+∞
21.8
20
*
L03, ,
ICD-O-3
+∞
21.8
20
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
21.8
20
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
21.8
20
*
WX408, ,
ICD-O-3
+∞
21.8
20
*
J010, ,
ICD-O-3
+∞
21.8
20
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
20.7
19
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
20.7
19
*
SPAT1325, ,
ICD-O-3
+∞
20.7
19
*
J05AB11, ,
ATC
valaciclovir; oral
+∞
20.7
19
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
20.7
19
*
WZA90, ,
ICD-O-3
+∞
20.7
19
*
FM1EE, ,
ICD-O-3
+∞
20.7
19
*
R21, ,
ICD-O-3
+∞
20.7
19
*
TPH04, ,
ICD-O-3
+∞
20.7
19
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
20.7
19
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
20.7
19
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
20.7
19
*
WX002, ,
ICD-O-3
+∞
20.7
19
*
CJE20, ,
ICD-O-3
+∞
20.7
19
*
SPAT1301, ,
ICD-O-3
+∞
19.5
18
*
U02, ,
ICD-O-3
+∞
19.5
18
*
R5180, ,
ICD-10 Finland
Headache
+∞
19.5
18
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
19.5
18
*
C08CA01, ,
ATC
amlodipine; oral
+∞
19.5
18
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
19.5
18
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
19.5
18
*
E000001, ,
ATC
+∞
19.5
18
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
19.5
18
*
C09CA06, ,
ATC
candesartan; oral
+∞
19.5
18
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
19.5
18
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
19.5
18
*
L01BA01, ,
ATC
methotrexate; systemic
+∞
19.5
18
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
19.5
18
*
NK4XE, ,
ICD-O-3
+∞
19.5
18
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
19.5
18
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
18.4
17
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
18.4
17
*
K045, ,
ICD-O-3
+∞
18.4
17
*
L04AX01, ,
ATC
azathioprine; systemic
+∞
18.4
17
*
SPAT1153, ,
ICD-O-3
+∞
18.4
17
*
SPAT1310, ,
ICD-O-3
+∞
18.4
17
*
R06AX22, ,
ATC
ebastine; oral
+∞
18.4
17
*
N06AB04, ,
ATC
citalopram; systemic
+∞
17.3
16
*
R104, ,
ICD-O-3
+∞
17.3
16
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
17.3
16
*
SDA04, ,
ICD-O-3
+∞
17.3
16
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
17.3
16
*
C09CA01, ,
ATC
losartan; oral
+∞
17.3
16
*
Z3226, ,
ICD-O-3
+∞
17.3
16
*
A03, ,
ICD-O-3
+∞
17.3
16
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
17.3
16
*
R06AX13, ,
ATC
loratadine; oral
+∞
17.3
16
*
TQX10, ,
ICD-O-3
+∞
17.3
16
*
SPAT1283, ,
ICD-O-3
+∞
17.3
16
*
SPAT1312, ,
ICD-O-3
+∞
17.3
16
*
Z718, ,
ICD-O-3
+∞
17.3
16
*
C03CA01, ,
ATC
furosemide; systemic
+∞
17.3
16
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
17.3
16
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
17.3
16
*
SPAT1253, ,
ICD-O-3
+∞
17.3
16
*
WW200, ,
ICD-O-3
+∞
17.3
16
*
FM1AE, ,
ICD-O-3
+∞
16.2
15
*
A46, ,
ICD-10 Finland
Erysipelas
+∞
16.2
15
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
16.2
15
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
16.2
15
*
L28, ,
ICD-O-3
+∞
16.2
15
*
L309, ,
ICD-10 Finland
Dermatitis, unspecified
+∞
16.2
15
*
SDE02, ,
ICD-O-3
+∞
16.2
15
*
WX320, ,
ICD-O-3
+∞
16.2
15
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
16.2
15
*
Z760, ,
ICD-O-3
+∞
16.2
15
*
Z712, ,
ICD-O-3
+∞
16.2
15
*
NG1AA, ,
ICD-O-3
+∞
16.2
15
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
16.2
15
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
16.2
15
*
PH2AE, ,
ICD-O-3
+∞
16.2
15
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
16.2
15
*
SFA40, ,
ICD-O-3
+∞
16.2
15
*
SDE03, ,
ICD-O-3
+∞
16.2
15
*
ZX120, ,
ICD-O-3
+∞
16.2
15
*
K0364, ,
ICD-O-3
+∞
15.0
14
*
WX402, ,
ICD-O-3
+∞
15.0
14
*
WX404, ,
ICD-O-3
+∞
15.0
14
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
15.0
14
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
15.0
14
*
ZY020, ,
ICD-O-3
+∞
15.0
14
*
R02, ,
ICD-O-3
+∞
15.0
14
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
15.0
14
*
C07AA05, ,
ATC
propranolol; systemic
+∞
15.0
14
*
Z048, ,
ICD-10 Finland
Examination and observation for other specified reasons
+∞
15.0
14
*
D07AD01, ,
ATC
clobetasol; topical
+∞
15.0
14
*
U072, ,
ICD-O-3
+∞
15.0
14
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
15.0
14
*
D01BA02, ,
ATC
terbinafine; oral
+∞
15.0
14
*
N06AB10, ,
ATC
escitalopram; oral
+∞
15.0
14
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
15.0
14
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
15.0
14
*
M545, ,
ICD-10 Finland
Low back pain
+∞
15.0
14
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
15.0
14
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
15.0
14
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
15.0
14
*
R5110, ,
ICD-O-3
+∞
15.0
14
*
R238, ,
ICD-O-3
+∞
15.0
14
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
15.0
14
*
U071, ,
ICD-O-3
+∞
15.0
14
*
ZXA10, ,
ICD-O-3
+∞
13.9
13
*
G01AA10, ,
ATC
clindamycin; vaginal
+∞
13.9
13
*
L01, ,
ICD-O-3
+∞
13.9
13
*
ND2AA, ,
ICD-O-3
+∞
13.9
13
*
J01MA14, ,
ATC
moxifloxacin; systemic
+∞
13.9
13
*
K85, ,
ICD-O-3
+∞
13.9
13
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
13.9
13
*
E000002, ,
ATC
+∞
13.9
13
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
13.9
13
*
D01AE16, ,
ATC
amorolfine; topical
+∞
13.9
13
*
A09, ,
ICD-O-3
+∞
13.9
13
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
13.9
13
*
J45, ,
ICD-O-3
+∞
13.9
13
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
13.9
13
*
SPAT1230, ,
ICD-O-3
+∞
13.9
13
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
13.9
13
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
13.9
13
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
13.9
13
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
13.9
13
*
Z017, ,
ICD-O-3
+∞
12.8
12
*
XCW99, ,
ICD-O-3
+∞
12.8
12
*
R03BB04, ,
ATC
tiotropium bromide; inhalant
+∞
12.8
12
*
R509, ,
ICD-O-3
+∞
12.8
12
*
R103, ,
ICD-O-3
+∞
12.8
12
*
H01, ,
ICD-O-3
+∞
12.8
12
*
NK6QA, ,
ICD-O-3
+∞
12.8
12
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
12.8
12
*
WYA30, ,
ICD-O-3
+∞
12.8
12
*
ZXD20, ,
ICD-O-3
+∞
12.8
12
*
UGC12, ,
ICD-O-3
+∞
12.8
12
*
M05BA04, ,
ATC
alendronic acid; oral
+∞
12.8
12
*
L309, ,
ICD-O-3
+∞
12.8
12
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
12.8
12
*
J209, ,
ICD-O-3
+∞
12.8
12
*
N06AX21, ,
ATC
duloxetine; oral
+∞
12.8
12
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
12.8
12
*
XF400, ,
ICD-O-3
+∞
12.8
12
*
R53, ,
ICD-O-3
+∞
12.8
12
*
M01AX05, ,
ATC
glucosamine; oral
+∞
12.8
12
*
Z014, ,
ICD-10 Finland
Gynaecological examination (general)(routine)
+∞
12.8
12
*
DMB20, ,
ICD-O-3
+∞
12.8
12
*
OAA65, ,
ICD-O-3
+∞
12.8
12
*
SGA01, ,
ICD-O-3
+∞
11.7
11
*
A07AA02, ,
ATC
nystatin; oral
+∞
11.7
11
*
D11, ,
ICD-O-3
+∞
11.7
11
*
104, ,
Kela drug reimbursment
Thyroid insufficiency
+∞
11.7
11
*
Z015, ,
ICD-10 Finland
Diagnostic skin and sensitization tests
+∞
11.7
11
*
OAA67, ,
ICD-O-3
+∞
11.7
11
*
N01, ,
ICD-O-3
+∞
11.7
11
*
FN1AC, ,
ICD-O-3
+∞
11.7
11
*
MA2HE, ,
ICD-O-3
+∞
11.7
11
*
H29, ,
ICD-O-3
+∞
11.7
11
*
R03AC03, ,
ATC
terbutaline; inhalant
+∞
11.7
11
*
XQ800, ,
ICD-O-3
+∞
11.7
11
*
ZXE20, ,
ICD-O-3
+∞
11.7
11
*
SHB00, ,
ICD-O-3
+∞
11.7
11
*
SPAT1148, ,
ICD-O-3
+∞
11.7
11
*
S21, ,
ICD-O-3
+∞
11.7
11
*
SPAT1262, ,
ICD-O-3
+∞
11.7
11
*
J320, ,
ICD-10 Finland
Chronic maxillary sinusitis
+∞
11.7
11
*
G03DC02, ,
ATC
norethisterone; oral
+∞
11.7
11
*
UJF30, ,
ICD-O-3
+∞
11.7
11
*
AA1CG, ,
ICD-O-3
+∞
11.7
11
*
H610, ,
ICD-10 Finland
Perichondritis of external ear
+∞
11.7
11
*
6500B, ,
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
+∞
11.7
11
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
11.7
11
*
R5180, ,
ICD-O-3
+∞
11.7
11
*
G442, ,
ICD-10 Finland
Tension-type headache
+∞
11.7
11
*
R96, ,
ICD-O-3
+∞
11.7
11
*
N05AH04, ,
ATC
quetiapine; oral
+∞
11.7
11
*
D01, ,
ICD-O-3
+∞
11.7
11
*
R06AX26, ,
ATC
fexofenadine; oral
+∞
11.7
11
*
M706, ,
ICD-O-3
+∞
11.7
11
*
M751, ,
ICD-O-3
+∞
11.7
11
*
U01, ,
ICD-O-3
+∞
11.7
11
*
A97, ,
ICD-O-3
+∞
11.7
11
*
H200, ,
ICD-10 Finland
Acute and subacute iridocyclitis
+∞
11.7
11
*
SPAT1324, ,
ICD-O-3
+∞
11.7
11
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
11.7
11
*
SAD01, ,
ICD-O-3
+∞
11.7
11
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
11.7
11
*
K0530, ,
ICD-O-3
+∞
11.7
11
*
R060, ,
ICD-O-3
+∞
10.6
10
*
G03DB01, ,
ATC
dydrogesterone; oral
+∞
10.6
10
*
CK2X4, ,
ICD-O-3
+∞
10.6
10
*
Z024, ,
ICD-O-3
+∞
10.6
10
*
WX700, ,
ICD-O-3
+∞
10.6
10
*
N300, ,
ICD-O-3
+∞
10.6
10
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
10.6
10
*
JN3AE, ,
ICD-O-3
+∞
10.6
10
*
MA1AE, ,
ICD-O-3
+∞
10.6
10
*
A46, ,
ICD-O-3
+∞
10.6
10
*
J01MA01, ,
ATC
ofloxacin; systemic
+∞
10.6
10
*
TPH07, ,
ICD-O-3
+∞
10.6
10
*
R42, ,
ICD-O-3
+∞
10.6
10
*
A04, ,
ICD-O-3
+∞
10.6
10
*
SPAT1216, ,
ICD-O-3
+∞
10.6
10
*
VALMI, ,
ICD-O-3
+∞
10.6
10
*
F29, ,
ICD-O-3
+∞
10.6
10
*
R074, ,
ICD-O-3
+∞
10.6
10
*
N30, ,
ICD-O-3
+∞
10.6
10
*
J01FA15, ,
ATC
telithromycin; oral
+∞
10.6
10
*
TNX10, ,
ICD-O-3
+∞
10.6
10
*
K044, ,
ICD-O-3
+∞
10.6
10
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
10.6
10
*
DFF00, ,
ICD-O-3
+∞
10.6
10
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
10.6
10
*
N951, ,
ICD-O-3
+∞
10.6
10
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
10.6
10
*
G560, ,
ICD-10 Finland
Carpal tunnel syndrome
+∞
10.6
10
*
WZC30, ,
ICD-O-3
+∞
10.6
10
*
EBA10, ,
ICD-O-3
+∞
10.6
10
*
G03AC03, ,
ATC
levonorgestrel; oral, implant
+∞
10.6
10
*
SPAT1308, ,
ICD-O-3
+∞
10.6
10
*
OAB48, ,
ICD-O-3
+∞
10.6
10
*
W00, ,
ICD-10 Finland
Fall on same level involving ice and snow
+∞
10.6
10
*
L88, ,
ICD-O-3
+∞
10.6
10
*
M01AH01, ,
ATC
celecoxib; oral
+∞
10.6
10
*
J01AA04, ,
ATC
lymecycline; systemic
+∞
10.6
10
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
10.6
10
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
10.6
10
*
A10BA02, ,
ATC
metformin; oral
+∞
10.6
10
*
L14, ,
ICD-O-3
+∞
10.6
10
*
C01CA24, ,
ATC
epinephrine; parenteral
+∞
10.6
10
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
10.6
10
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
10.6
10
*
M01AC01, ,
ATC
piroxicam; systemic, rectal
+∞
10.6
10
*
SFA00, ,
ICD-O-3
+∞
10.6
10
*
H0410, ,
ICD-10 Finland
Dry eye syndrome
+∞
10.6
10
*
XCK10, ,
ICD-O-3
+∞
10.6
10
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
10.6
10
*
R529, ,
ICD-O-3
+∞
10.6
10
*
D07CC01, ,
ATC
betamethasone and antibiotics; topical
+∞
10.6
10
*
WX602, ,
ICD-O-3
+∞
9.6
9
*
SHA01, ,
ICD-O-3
+∞
9.6
9
*
CK2S4, ,
ICD-O-3
+∞
9.6
9
*
GD1UA, ,
ICD-O-3
+∞
9.6
9
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
9.6
9
*
K020, ,
ICD-O-3
+∞
9.6
9
*
R101, ,
ICD-O-3
+∞
9.6
9
*
Z0389, ,
ICD-10 Finland
Observation for other suspected diseases and conditions
+∞
9.6
9
*
R01AD05, ,
ATC
budesonide; nasal
+∞
9.6
9
*
N06AB06, ,
ATC
sertraline; oral
+∞
9.6
9
*
K210, ,
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
+∞
9.6
9
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
9.6
9
*
L12, ,
ICD-O-3
+∞
9.6
9
*
J20, ,
ICD-O-3
+∞
9.6
9
*
L02, ,
ICD-O-3
+∞
9.6
9
*
H02, ,
ICD-O-3
+∞
9.6
9
*
K80, ,
ICD-O-3
+∞
9.6
9
*
UDH02, ,
ICD-O-3
+∞
9.6
9
*
JN1AE, ,
ICD-O-3
+∞
9.6
9
*
S01AA01, ,
ATC
chloramphenicol; ophthalmic
+∞
9.6
9
*
H60, ,
ICD-O-3
+∞
9.6
9
*
K802, ,
ICD-10 Finland
Calculus of gallbladder without cholecystitis
+∞
9.6
9
*
NA1BG, ,
ICD-O-3
+∞
9.6
9
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
9.6
9
*
B01AA03, ,
ATC
warfarin; systemic
+∞
9.6
9
*
M01AH02, ,
ATC
rofecoxib; oral
+∞
9.6
9
*
NH3AA, ,
ICD-O-3
+∞
9.6
9
*
J01CF05, ,
ATC
flucloxacillin; systemic
+∞
9.6
9
*
K040, ,
ICD-O-3
+∞
9.6
9
*
L04AA13, ,
ATC
[U] leflunomide
+∞
9.6
9
*
M511, ,
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
+∞
9.6
9
*
D07BC01, ,
ATC
betamethasone and antiseptics; topical
+∞
8.5
8
*
N06CA01, ,
ATC
amitriptyline and psycholeptics; systemic
+∞
8.5
8
*
H601, ,
ICD-O-3
+∞
8.5
8
*
GD1BD, ,
ICD-O-3
+∞
8.5
8
*
LX1AE, ,
ICD-O-3
+∞
8.5
8
*
H609, ,
ICD-10 Finland
Otitis externa, unspecified
+∞
8.5
8
*
D649, ,
ICD-10 Finland
Anaemia, unspecified
+∞
8.5
8
*
TKC20, ,
ICD-O-3
+∞
8.5
8
*
WZC10, ,
ICD-O-3
+∞
8.5
8
*
ZYC01, ,
ICD-O-3
+∞
8.5
8
*
K0380, ,
ICD-O-3
+∞
8.5
8
*
O049, ,
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
+∞
8.5
8
*
A04AA01, ,
ATC
ondansetron; systemic, rectal
+∞
8.5
8
*
L82, ,
ICD-O-3
+∞
8.5
8
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
8.5
8
*
XKD00, ,
ICD-O-3
+∞
8.5
8
*
N832, ,
ICD-10 Finland
Other and unspecified ovarian cysts
+∞
8.5
8
*
L29, ,
ICD-O-3
+∞
8.5
8
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
8.5
8
*
J459, ,
ICD-O-3
+∞
8.5
8
*
J209, ,
ICD-10 Finland
Acute bronchitis, unspecified
+∞
8.5
8
*
A44, ,
ICD-O-3
+∞
8.5
8
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
8.5
8
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
8.5
8
*
H109, ,
ICD-O-3
+∞
8.5
8
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
8.5
8
*
SGA02, ,
ICD-O-3
+∞
8.5
8
*
A01, ,
ICD-O-3
+∞
8.5
8
*
M791, ,
ICD-O-3
+∞
8.5
8
*
UDC00, ,
ICD-O-3
+∞
8.5
8
*
G01AF05, ,
ATC
econazole; vaginal
+∞
8.5
8
*
W19, ,
ICD-10 Finland
Unspecified fall
+∞
8.5
8
*
JKA21, ,
ICD-O-3
+∞
8.5
8
*
N05CF02, ,
ATC
zolpidem; oral
+∞
8.5
8
*
J189, ,
ICD-O-3
+∞
8.5
8
*
D07AB08, ,
ATC
desonide; topical
+∞
8.5
8
*
M531, ,
ICD-O-3
+∞
8.5
8
*
S29, ,
ICD-O-3
+∞
8.5
8
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
8.5
8
*
MA2AE, ,
ICD-O-3
+∞
8.5
8
*
C09AA02, ,
ATC
enalapril; systemic
+∞
8.5
8
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
8.5
8
*
NA3BG, ,
ICD-O-3
+∞
8.5
8
*
G02BA03, ,
ATC
plastic IUD with progestogen
+∞
8.5
8
*
R03AK10, ,
ATC
vilanterol and fluticasone furoate; inhalant
+∞
8.5
8
*
T90, ,
ICD-O-3
+∞
8.5
8
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
8.5
8
*
Z3229, ,
ICD-O-3
+∞
8.5
8
*
SGA04, ,
ICD-O-3
+∞
8.5
8
*
EB1VA, ,
ICD-O-3
+∞
8.5
8
*
K0365, ,
ICD-O-3
+∞
8.5
8
*
M02AA15, ,
ATC
diclofenac; topical
+∞
8.5
8
*
K0510, ,
ICD-O-3
+∞
8.5
8
*
L16, ,
ICD-O-3
+∞
8.5
8
*
Z302, ,
ICD-10 Finland
Sterilization
+∞
8.5
8
*
WX100, ,
ICD-O-3
+∞
8.5
8
*
A29, ,
ICD-O-3
+∞
8.5
8
*
C05AA08, ,
ATC
fluocortolone; rectal, topical
+∞
8.5
8
*
F419, ,
ICD-10 Finland
Anxiety disorder, unspecified
+∞
8.5
8
*
R065, ,
ICD-10 Finland
Mouth breathing
+∞
8.5
8
*
N393, ,
ICD-10 Finland
Stress incontinence
+∞
8.5
8
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
8.5
8
*
GD1QA, ,
ICD-O-3
+∞
8.5
8
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.4
7
*
NA3AA, ,
ICD-O-3
+∞
7.4
7
*
M17, ,
ICD-O-3
+∞
7.4
7
*
R5140, ,
ICD-O-3
+∞
7.4
7
*
K30, ,
ICD-O-3
+∞
7.4
7
*
J22, ,
ICD-O-3
+∞
7.4
7
*
Z014, ,
ICD-O-3
+∞
7.4
7
*
NGD05, ,
ICD-O-3
+∞
7.4
7
*
J451, ,
ICD-10 Finland
Nonallergic asthma
+∞
7.4
7
*
R21, ,
ICD-10 Finland
Rash and other nonspecific skin eruption
+∞
7.4
7
*
A07EC02, ,
ATC
mesalazine; oral, rectal
+∞
7.4
7
*
R03BC03, ,
ATC
nedocromil; inhalant
+∞
7.4
7
*
A11, ,
ICD-O-3
+∞
7.4
7
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
7.4
7
*
GD1AD, ,
ICD-O-3
+∞
7.4
7
*
M54, ,
ICD-O-3
+∞
7.4
7
*
SPAT1156, ,
ICD-O-3
+∞
7.4
7
*
HA1AE, ,
ICD-O-3
+∞
7.4
7
*
SFC92, ,
ICD-O-3
+∞
7.4
7
*
TQW40, ,
ICD-O-3
+∞
7.4
7
*
G43, ,
ICD-O-3
+∞
7.4
7
*
WX105, ,
ICD-O-3
+∞
7.4
7
*
L04, ,
ICD-O-3
+∞
7.4
7
*
SGC00, ,
ICD-O-3
+∞
7.4
7
*
XLD00, ,
ICD-O-3
+∞
7.4
7
*
J342, ,
ICD-10 Finland
Deviated nasal septum
+∞
7.4
7
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
7.4
7
*
Z033, ,
ICD-10 Finland
Observation for suspected nervous system disorder
+∞
7.4
7
*
M722, ,
ICD-10 Finland
Plantar fascial fibromatosis
+∞
7.4
7
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
7.4
7
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
7.4
7
*
Z3232, ,
ICD-O-3
+∞
7.4
7
*
50099, ,
ICD-8 Finland
Hypertrophy of tonsils and adenoids
+∞
7.4
7
*
TLC00, ,
ICD-O-3
+∞
7.4
7
*
F510, ,
ICD-O-3
+∞
7.4
7
*
G01AF01, ,
ATC
metronidazole; vaginal
+∞
7.4
7
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
7.4
7
*
SXA20, ,
ICD-O-3
+∞
7.4
7
*
FB1BD, ,
ICD-O-3
+∞
7.4
7
*
Z2446, ,
ICD-O-3
+∞
7.4
7
*
H160, ,
ICD-10 Finland
Corneal ulcer
+∞
7.4
7
*
HA1AA, ,
ICD-O-3
+∞
7.4
7
*
F412, ,
ICD-O-3
+∞
7.4
7
*
D509, ,
ICD-10 Finland
Iron deficiency anaemia, unspecified
+∞
7.4
7
*
Z03, ,
ICD-O-3
+∞
7.4
7
*
LC2AE, ,
ICD-O-3
+∞
7.4
7
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
7.4
7
*
JN4BD, ,
ICD-O-3
+∞
7.4
7
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
7.4
7
*
B01AB10, ,
ATC
tinzaparin; parenteral
+∞
7.4
7
*
SPAT1254, ,
ICD-O-3
+∞
7.4
7
*
S15, ,
ICD-O-3
+∞
7.4
7
*
WX006, ,
ICD-O-3
+∞
7.4
7
*
O244, ,
ICD-10 Finland
Diabetes mellitus arising in pregnancy
+∞
7.4
7
*
H920, ,
ICD-O-3
+∞
7.4
7
*
Z000, ,
ICD-O-3
+∞
7.4
7
*
Z712, ,
ICD-10 Finland
Person consulting for explanation of investigation findings
+∞
7.4
7
*
S01, ,
ICD-O-3
+∞
7.4
7
*
R11, ,
ICD-10 Finland
Nausea and vomiting
+∞
7.4
7
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
7.4
7
*
S01ED51, ,
ATC
timolol, combinations; ophthalmic
+∞
7.4
7
*
A28, ,
ICD-O-3
+∞
7.4
7
*
H0410, ,
ICD-O-3
+∞
7.4
7
*
H81, ,
ICD-O-3
+∞
7.4
7
*
R03AL01, ,
ATC
fenoterol and ipratropium bromide; inhalant
+∞
7.4
7
*
R13, ,
ICD-10 Finland
Dysphagia
+∞
7.4
7
*
A01AB09, ,
ATC
miconazole; local oral
+∞
7.4
7
*
R062, ,
ICD-10 Finland
Wheezing
+∞
7.4
7
*
R2130, ,
ICD-O-3
+∞
7.4
7
*
EP1AE, ,
ICD-O-3
+∞
7.4
7
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
7.4
7
*
D07XC01, ,
ATC
betamethasone; topical
+∞
7.4
7
*
Z258, ,
ICD-O-3
+∞
7.4
7
*
N17, ,
ICD-O-3
+∞
7.4
7
*
B01AB04, ,
ATC
dalteparin; parenteral
+∞
6.3
6
*
R03AC13, ,
ATC
formoterol; inhalant
+∞
6.3
6
*
K083, ,
ICD-O-3
+∞
6.3
6
*
C09AA05, ,
ATC
ramipril; oral
+∞
6.3
6
*
K041, ,
ICD-O-3
+∞
6.3
6
*
XCK00, ,
ICD-O-3
+∞
6.3
6
*
E11, ,
ICD-O-3
+∞
6.3
6
*
NGB20, ,
ICD-O-3
+∞
6.3
6
*
L04AA06, ,
ATC
mycophenolic acid; systemic
+∞
6.3
6
*
E118, ,
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
+∞
6.3
6
*
XPX99, ,
ICD-O-3
+∞
6.3
6
*
NG1BG, ,
ICD-O-3
+∞
6.3
6
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
6.3
6
*
H531, ,
ICD-10 Finland
Subjective visual disturbances
+∞
6.3
6
*
R2110, ,
ICD-O-3
+∞
6.3
6
*
SGB10, ,
ICD-O-3
+∞
6.3
6
*
H438, ,
ICD-10 Finland
Other disorders of vitreous body
+∞
6.3
6
*
SPAT1028, ,
ICD-O-3
+∞
6.3
6
*
L20, ,
ICD-O-3
+∞
6.3
6
*
NE1AA, ,
ICD-O-3
+∞
6.3
6
*
F03, ,
ICD-O-3
+∞
6.3
6
*
JN3BD, ,
ICD-O-3
+∞
6.3
6
*
N02BF01, ,
ATC
gabapentin; oral
+∞
6.3
6
*
U71, ,
ICD-O-3
+∞
6.3
6
*
JN4AD, ,
ICD-O-3
+∞
6.3
6
*
D02, ,
ICD-O-3
+∞
6.3
6
*
L04AD01, ,
ATC
ciclosporin; systemic
+∞
6.3
6
*
M359, ,
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
6.3
6
*
S01BA01, ,
ATC
dexamethasone; ophthalmic
+∞
6.3
6
*
K0880, ,
ICD-O-3
+∞
6.3
6
*
L05, ,
ICD-O-3
+∞
6.3
6
*
F458, ,
ICD-O-3
+∞
6.3
6
*
G430, ,
ICD-10 Finland
Migraine without aura [common migraine]
+∞
6.3
6
*
SAB01, ,
ICD-O-3
+∞
6.3
6
*
E03, ,
ICD-O-3
+∞
6.3
6
*
ACC51, ,
ICD-O-3
+∞
6.3
6
*
M139, ,
ICD-10 Finland
Arthritis, unspecified
+∞
6.3
6
*
QAE10, ,
ICD-O-3
+∞
6.3
6
*
MCA10, ,
ICD-O-3
+∞
6.3
6
*
M544, ,
ICD-O-3
+∞
6.3
6
*
GD1PA, ,
ICD-O-3
+∞
6.3
6
*
G03FA12, ,
ATC
medroxyprogesterone and estrogen; systemic
+∞
6.3
6
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
6.3
6
*
A05, ,
ICD-O-3
+∞
6.3
6
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
6.3
6
*
M179, ,
ICD-O-3
+∞
6.3
6
*
H264, ,
ICD-10 Finland
After-cataract
+∞
6.3
6
*
A06AD11, ,
ATC
lactulose; oral
+∞
6.3
6
*
L04AA01, ,
ATC
[U] ciclosporin
+∞
6.3
6
*
G04BD08, ,
ATC
solifenacin; oral
+∞
6.3
6
*
XF404, ,
ICD-O-3
+∞
6.3
6
*
A99, ,
ICD-O-3
+∞
6.3
6
*
Z315, ,
ICD-10 Finland
Genetic counselling
+∞
6.3
6
*
R29, ,
ICD-O-3
+∞
6.3
6
*
SPAT1260, ,
ICD-O-3
+∞
6.3
6
*
SGB30, ,
ICD-O-3
+∞
6.3
6
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
6.3
6
*
P03, ,
ICD-O-3
+∞
6.3
6
*
K219, ,
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
+∞
6.3
6
*
OAB91, ,
ICD-O-3
+∞
6.3
6
*
A10BH01, ,
ATC
sitagliptin; oral
+∞
6.3
6
*
R75, ,
ICD-O-3
+∞
6.3
6
*
H100, ,
ICD-O-3
+∞
6.3
6
*
DM1QA, ,
ICD-O-3
+∞
6.3
6
*
M949, ,
ICD-10 Finland
Disorder of cartilage, unspecified
+∞
6.3
6
*
EB4VA, ,
ICD-O-3
+∞
6.3
6
*
H201, ,
ICD-10 Finland
Chronic iridocyclitis
+∞
6.3
6
*
RD211, ,
ICD-O-3
+∞
6.3
6
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
6.3
6
*
NGF25, ,
ICD-O-3
+∞
6.3
6
*
R55, ,
ICD-10 Finland
Syncope and collapse
+∞
6.3
6
*
SPAT1097, ,
ICD-O-3
+∞
6.3
6
*
R06AX12, ,
ATC
terfenadine; oral
+∞
6.3
6
*
S76, ,
ICD-O-3
+∞
6.3
6
*
S82, ,
ICD-O-3
+∞
6.3
6
*
R91, ,
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
+∞
6.3
6
*
H620, A46,
ICD-10 Finland
Otitis externa in erysipelas
+∞
6.3
6
*
SPAT1240, ,
ICD-O-3
+∞
6.3
6
*
J310, ,
ICD-10 Finland
Chronic rhinitis
+∞
6.3
6
*
SBB10, ,
ICD-O-3
+∞
6.3
6
*
S934, ,
ICD-10 Finland
Sprain and strain of ankle
+∞
6.3
6
*
-44, ,
ICD-O-3
+∞
6.3
6
*
N03AG01, ,
ATC
valproic acid; systemic, rectal
+∞
6.3
6
*
R03BA08, ,
ATC
ciclesonide; inhalant
+∞
6.3
6
*
G431, ,
ICD-10 Finland
Migraine with aura [classical migraine]
+∞
6.3
6
*
D06, ,
ICD-O-3
+∞
6.3
6
*
OAB42, ,
ICD-O-3
+∞
6.3
6
*
U07, ,
ICD-O-3
+∞
6.3
6
*
B03BA03, ,
ATC
hydroxocobalamin; parenteral
+∞
6.3
6
*
SXB00, ,
ICD-O-3
+∞
6.3
6
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
6.3
6
*
TDM10, ,
ICD-O-3
+∞
6.3
6
*
NB1AA, ,
ICD-O-3
+∞
6.3
6
*
S0251, ,
ICD-O-3
+∞
6.3
6
*
R01AD11, ,
ATC
triamcinolone; nasal
+∞
6.3
6
*
SPAT1305, ,
ICD-O-3
+∞
6.3
6
*
G03DA02, ,
ATC
medroxyprogesterone; systemic
+∞
6.3
6
*
L089, ,
ICD-O-3
+∞
6.3
6
*
SPAT1360, ,
ICD-O-3
+∞
6.3
6
*
SPAT1250, ,
ICD-O-3
+∞
6.3
6
*
XF402, ,
ICD-O-3
+∞
6.3
6
*
LCA06, ,
ICD-O-3
+∞
6.3
6
*
SCA02, ,
ICD-O-3
+∞
6.3
6
*
WZA00, ,
ICD-O-3
+∞
6.3
6
*
G01AF04, ,
ATC
miconazole; vaginal
+∞
6.3
6
*
H811, ,
ICD-10 Finland
Benign paroxysmal vertigo
+∞
6.3
6
*
F430, ,
ICD-O-3
+∞
6.3
6
*
H023, ,
ICD-10 Finland
Blepharochalasis
+∞
6.3
6
*
M751, ,
ICD-10 Finland
Rotator cuff syndrome
+∞
6.3
6
*
K081, ,
ICD-O-3
+∞
6.3
6
*
N07CA01, ,
ATC
betahistine; oral
+∞
6.3
6
*
P06, ,
ICD-O-3
+∞
6.3
6
*
I350, ,
ICD-10 Finland
Aortic (valve) stenosis
+∞
6.3
6
*
J450, ,
ICD-10 Finland
Predominantly allergic asthma
+∞
6.3
6
*
EBA30, ,
ICD-O-3
+∞
6.3
6
*
O470, ,
ICD-10 Finland
False labour before 37 completed weeks of gestation
+∞
6.3
6
*
R07, ,
ICD-O-3
+∞
6.3
6
*
XF600, ,
ICD-O-3
+∞
6.3
6
*
E883A, ,
ICD-9 Finland
Fall into hole or other opening in surface
+∞
6.3
6
*
E039, ,
ICD-O-3
+∞
6.3
6
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
6.3
6
*
R229, ,
ICD-O-3
+∞
6.3
6
*
H609, ,
ICD-O-3
+∞
6.3
6
*
N02CC04, ,
ATC
rizatriptan; oral
+∞
6.3
6
*
N06AA09, ,
ATC
amitriptyline; systemic
+∞
6.3
6
*
M232, ,
ICD-10 Finland
Derangement of meniscus due to old tear or injury
+∞
6.3
6
*
L11, ,
ICD-O-3
+∞
6.3
6
*
K449, ,
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
+∞
6.3
6
*
G473, ,
ICD-O-3
+∞
6.3
6
*
SPAT1033, ,
ICD-O-3
+∞
6.3
6
*
S01ED01, ,
ATC
timolol; ophthalmic
+∞
6.3
6
*
E039, ,
ICD-10 Finland
Hypothyroidism, unspecified
+∞
6.3
6
*
N62, ,
ICD-10 Finland
Hypertrophy of breast
+∞
6.3
6
*
UJF45, ,
ICD-O-3
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
60
345
3.67
6.83
5.0
3.5
0.00
0.00
estimate
-0.00
12
78
60
347
3.63
6.73
6.5
4.8
0.00
0.00
estimate
-0.00
12
75
60
350
3.58
6.57
5.0
3.5
0.00
0.00
estimate
-0.00
12
71
75
534
5.19
6.54
9.7
3.9
10.73
10.16
mm/h
0.16
75
486
15
24
7.38
6.53
1.7
1.5
—
—
—
0
0
33
150
2.99
5.30
1.6
1.3
10.40
39.19
iu/ml
—
10
48
11
16
7.74
5.14
1.5
1.3
—
—
—
0
0
9
10
9.92
4.92
1.2
1.2
—
—
—
0
0
9
10
9.92
4.92
1.2
1.2
—
—
—
0
0
9
10
9.92
4.92
1.2
1.2
—
—
—
0
0
9
10
9.92
4.92
1.2
1.2
—
—
—
0
0
9
10
9.92
4.92
1.2
1.2
—
—
—
0
0
11
21
5.86
4.32
1.3
1.0
—
—
—
0
0
49
298
2.57
4.24
5.4
5.4
1.21
1.22
mmol/l
0.23
43
250
8
11
7.91
3.96
1.1
1.2
—
—
—
0
0
34
182
2.47
3.76
2.8
2.5
0.15
0.42
e6/l
1.20
29
141
29
147
2.50
3.58
1.3
1.3
1.12
9.04
u/ml
1.65
13
59
38
223
2.30
3.35
3.3
2.8
—
—
—
0
0
18
80
2.60
2.85
2.2
1.7
—
—
—
0
0
28
153
2.25
2.85
2.6
1.7
0.49
1.32
mg/l
1.84
23
124
29
162
2.21
2.79
1.3
1.3
4.59
0.93
u/ml
—
9
45
5
6
8.76
2.78
1.0
1.5
—
—
—
0
0
5
6
8.76
2.78
1.2
1.0
—
—
—
0
0
43
282
2.09
2.73
5.3
3.5
—
—
—
0
0
9
26
3.75
2.57
8.2
8.5
23.67
24.30
mmol/l
—
9
26
37
236
2.02
2.48
3.0
3.1
33.35
32.19
u/l
0.10
37
222
15
67
2.51
2.34
6.2
6.0
105.73
103.79
mmol/l
0.84
15
67
32
197
2.02
2.34
6.2
3.7
0.00
0.00
estimate
-0.00
12
73
5
9
5.83
2.24
1.2
1.7
—
—
—
0
0
5
9
5.83
2.24
1.2
1.7
—
—
—
0
0
14
62
2.51
2.22
2.7
4.0
236.64
248.81
u/l
0.27
14
62
41
283
1.89
2.10
3.8
3.5
35.77
36.26
g/l
0.24
41
267
15
75
2.22
1.83
2.9
1.7
22.27
25.11
%
0.40
15
64
9
36
2.68
1.80
6.9
4.3
23.89
24.50
mmol/l
—
9
36
41
295
1.77
1.76
23.2
10.0
1.32
1.15
inr
0.61
19
91
8
31
2.74
1.71
1.8
2.4
1.04
1.51
%
—
8
31
6
20
3.15
1.61
1.3
1.8
—
—
—
0
0
11
51
2.33
1.58
2.6
1.6
—
—
—
0
0
18
103
1.95
1.56
2.7
2.3
0.85
0.84
e6/l
—
10
63
7
27
2.73
1.55
1.1
1.4
—
—
—
0
0
22
136
1.84
1.52
1.7
1.5
—
—
—
0
0
7
28
2.63
1.49
1.9
1.4
—
—
—
0
0
10
46
2.33
1.46
7.6
5.3
0.99
1.36
mmol/l
—
10
46
6
22
2.86
1.46
1.3
2.0
—
—
—
0
0
16
90
1.96
1.45
2.6
2.6
0.81
3.51
e6/l
—
8
51
9
40
2.40
1.45
1.4
1.5
—
—
—
0
0
19
115
1.85
1.40
4.5
3.1
182.00
167.84
ng/l
—
8
79
11
55
2.15
1.34
2.6
1.5
—
—
—
0
0
11
55
2.15
1.34
1.2
1.2
45.87
143.88
iu/ml
—
6
20
40
302
1.63
1.34
4.3
2.6
123.45
101.56
ug/l
0.36
40
282
50
402
1.61
1.28
4.0
3.9
6.21
6.61
mmol/l
1.07
50
376
40
306
1.59
1.25
2.0
2.4
—
—
—
0
0
16
95
1.85
1.25
3.8
1.7
11.99
14.46
umol/l
0.88
16
85
5
20
2.59
1.17
1.6
1.4
—
—
—
0
0
21
139
1.68
1.15
1.9
2.2
—
—
—
0
0
32
238
1.56
1.10
2.0
1.9
92.21
95.78
pmol/l
0.17
20
128
33
249
1.54
1.06
4.4
3.7
17.57
45.94
ng/l
1.02
21
159
13
78
1.79
0.98
3.5
2.1
286.31
358.76
nmol/l
0.66
13
71
70
630
1.71
0.96
32.6
14.2
14.38
14.90
%
0.57
70
619
0
25
0.00
0.80
0.0
2.2
—
2.63
—
0
20
5
23
2.25
0.77
1.4
1.1
—
—
—
0
0
5
24
2.15
0.76
1.0
1.9
—
—
—
0
0
5
26
1.98
0.72
2.6
1.5
—
—
—
0
0
5
26
1.98
0.72
3.6
3.4
24.68
24.75
mmol/l
—
5
26
7
44
1.64
0.67
1.0
1.1
—
—
—
0
0
10
67
1.56
0.52
3.4
3.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
1.10
—
0
16
0
17
0.00
0.41
0.0
1.6
—
24.96
—
0
17
53
485
1.26
0.40
3.6
3.2
—
—
—
0
0
6
43
1.43
0.36
1.7
1.2
—
—
—
0
0
11
138
0.77
0.28
1.7
1.7
474.82
483.59
pmol/l
0.05
11
119
9
75
1.22
0.26
3.3
2.7
6.87
7.88
umol/l
—
9
64
10
78
1.32
0.25
4.0
6.1
—
—
—
0
0
10
79
1.30
0.23
3.3
2.9
0.95
1.01
mmol/l
—
10
74
11
89
1.27
0.22
2.3
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
11
100
1.12
0.05
2.5
2.1
—
—
—
0
0
14
150
0.92
0.04
1.3
1.4
—
—
—
0
0
56
549
1.06
0.04
5.9
4.3
14.75
14.62
pmol/l
0.13
56
513
17
177
0.95
0.01
6.4
5.1
1.93
1.82
ug/l
0.06
17
161
14
141
0.99
0.00
5.1
4.4
24.52
20.80
%
—
6
64
6
65
0.92
0.00
2.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
70
700
1.00
-0.00
3.7
4.5
1.53
1.50
mmol/l
0.20
70
647
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
56.80
—
0
5
0
9
0.00
-0.00
0.0
5.7
—
127.19
—
0
9
0
5
0.00
-0.00
0.0
4.8
—
—
—
0
0
9
89
1.01
-0.00
1.4
1.7
1.30
1.35
%
—
9
77
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_RELAPSPOLYCHONDR and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_RELAPSPOLYCHONDR.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_RELAPSPOLYCHONDR – Relapsing polychondritis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data